Boston, MA -- (SBWIRE) -- 10/08/2013 -- Introduction

The BRIC OTC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value 2008-12, and forecast to 2017). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the OTC pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC OTC pharmaceuticals market
- Leading company profiles reveal details of key OTC pharmaceuticals players' BRIC operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the BRIC OTC pharmaceuticals market with five year forecasts
- Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country

View Full Report Details and Table of Contents

Highlights

Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the OTC pharmaceuticals industry and had a total market value of $29,595.5 million in 2012. Brazil was the fastest growing country with a CAGR of 12.7% over the 2008-12 period.
Within the OTC pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $15,615.7 million in 2012. This was followed by Russia, Brazil and India with a value of $6,373.7, $5,771.9, and $1,834.2 million, respectively.
China is expected to lead the OTC pharmaceuticals industry in the BRIC nations with a value of $21,948.0 million in 2017, followed by Brazil, Russia, India with expected values of $9,908.9, $9,105.6 and $2,913.5 million, respectively.

Your key questions answered

- What was the size of the BRIC OTC pharmaceuticals market by value in 2012?
- What will be the size of the BRIC OTC pharmaceuticals market in 2017?
- What factors are affecting the strength of competition in the BRIC OTC pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the BRIC OTC pharmaceuticals market?

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide
- OTC Pharmaceuticals - North America (NAFTA) Industry Guide
- OTC Pharmaceuticals - Scandinavia Industry Guide
- Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
- OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide
- OTC Pharmaceuticals: Global Industry Guide
- OTC Pharmaceuticals: Global Industry Almanac
- Pharmaceuticals - Global Group of Eight (G8) Industry Guide
- Pharmaceuticals - Top 5 Emerging Markets Industry Guide
- Pharmaceuticals: Global Industry Guide